|

Standard of Care Neoadjuvant Chemotherapy (NAC) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Wake Forest University Health Sciences1

Indications

  • Vitamin D Deficiency1
  • Invasive Breast Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1
  • Cancer1

Winston-Salem, North Carolina1 trial

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest Baptist Health Sciences

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.